Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole for Cognitive Enhancement in Bipolar Disorder
NCT00597896Phase 4Completed
- Sponsor
- Northwell Health
- Start
- Oct 2005
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bipolar disorder (BD) comparing Active pramipexole with Placebo pramipexole (2 arms). Primary endpoints: Weschler Adult Intelligence Scale-Third Edition (WAIS-III) Digit Span Subtest (Digits Forward) at 8 weeks, Weschler Adult Intelligence Scale-Third Edition (WAIS-III) Digit Span Subtest (Digits Backward) at 8 weeks and 7 more. Started Oct 2005; status: completed.
02
Drugs
pramipexole
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00597896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00597896.